Sign in

Neuroendocrine tumours trials, also abroad

245 open Neuroendocrine tumours trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States89
China62
France41
Italy25
Canada16
Spain16
Germany14
Netherlands13
Poland12
Australia10
South Korea9
Belgium8
United Kingdom7
Brazil6
Japan6
Mexico5
Sweden5
Taiwan5
Austria4
Hungary4
Puerto Rico4
Portugal4
Czechia3
India3
Norway3
Argentina2
Switzerland2
Chile2
Finland2
Greece2
Israel2
New Zealand2
Türkiye2
Bulgaria1
Algeria1
Egypt1
Georgia1
Hong Kong1
Peru1
Réunion1
Romania1
Russia1
Saudi Arabia1
Singapore1
Ukraine1
Uruguay1

The same trial often runs in several countries

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy has 3 sites in Denmark and runs in 29 countries. If a site near you is full, another one may still take people.

See DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy in all 29 countries